Oral semaglutide improves all metabolic syndrome components in hypothyroid T2DM patients over 6 months | Research

The takeaway

In 51 patients with hypothyroidism and T2DM, 6 months of oral semaglutide 14 mg significantly reduced HbA1c (-6.7%), BMI, blood pressure, and triglycerides while increasing HDL—improving all metabolic syndrome components.

All MetS components improved
Oral semaglutide improved every metabolic syndrome parameter in hypothyroid diabetic patients—a population with compounded metabolic dysfunction

What the researchers found

HbA1c: -6.7% (p significant). BMI: significantly reduced. SBP and DBP: significantly reduced. Triglycerides: significantly reduced (p=0.002). HDL: increased. 51 patients; hypothyroid + T2DM; oral semaglutide 14 mg; 6 months.

Why it matters

Hypothyroid diabetic patients are often treatment-resistant due to compounded metabolic dysfunction. Showing oral semaglutide works in this complex population addresses a real clinical gap.

How the study worked

Single-center retrospective cohort. 51 adults with hypothyroidism + T2DM. Oral semaglutide 14 mg daily for 6 months. HbA1c, BMI, BP, lipid panel.

What this study cannot tell us

Small retrospective study (51 patients). Single center. No control group. Levothyroxine interaction not fully explored. Short follow-up.

How to read the evidence

Small retrospective cohort without controls. Good for real-world hypothesis but limited evidence level.

When this study was published

Published in 2025.

The bigger picture

Hypothyroidism and diabetes frequently coexist. Demonstrating oral semaglutide effectiveness in this dual-pathology population expands its proven utility to complex metabolic presentations.

Questions still open

Does semaglutide interact with levothyroxine absorption?
Should thyroid function be optimized before starting GLP-1 therapy?
Is oral semaglutide better than injectable in hypothyroid patients?

Common questions

Does semaglutide work if you also have thyroid problems?

Yes. This study of 51 patients with both hypothyroidism and diabetes showed oral semaglutide improved blood sugar, weight, blood pressure, and cholesterol over 6 months. All components of metabolic syndrome improved despite the added complexity of thyroid disease.

Can I take semaglutide with thyroid medication?

This study used oral semaglutide alongside levothyroxine treatment. While it appeared safe, the authors note that potential interactions between the two oral medications need further study. Both have specific fasting requirements that should be discussed with your doctor.

Read the original research

Modulation of metabolic syndrome components by oral semaglutide in hypothyroid-T2DM patients: a retrospective analysis.

Journal of medicine and life, 18(12), 1094-1099

View on PubMed ↗Publisher’s paper ↗

Citation

Tilici, Dana-Mihaela; Costinescu, Ruxandra-Mihaela; Paun, Diana-Loreta; Paun, Sorin Constantin; Guja, Cristian. (2025). Modulation of metabolic syndrome components by oral semaglutide in hypothyroid-T2DM patients: a retrospective analysis.. Journal of medicine and life, 18(12), 1094-1099. https://doi.org/10.25122/jml-2025-0144